Evidence map›Paper›PMID 20007532›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2010

Surfactant protein B propeptide contains a saposin-like protein domain with antimicrobial activity at low pH.

Li Yang, Jan Johansson, Ross Ridsdale, Hanna Willander, Michael Fitzen, Henry T Akinbi, Timothy E Weaver

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
2.4field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed, 67 citations in OpenAlex.

  1. Trial
  2. A therapy for suppressing canonical and noncanonical SARS-CoV-2 viral entry and an intrinsic intrapulmonary inflammatory response.Proceedings of the National Academy of Sciences of the United States of America · 2024
    Article
  3. Review
  4. Article
  5. Pulmonary surfactant as a versatile biomaterial to fight COVID-19.Journal of controlled release : official journal of the Controlled Release Society · 2022
    Review
  6. Article
  7. Article
  8. Synergistic Action of Antimicrobial Lung Proteins againstInternational journal of molecular sciences · 2021
    Article
  9. Article
  10. Review
  11. Aging and Lung Disease.Annual review of physiology · 2020
    Review
  12. The Inhibitory Effect of CurosurfFrontiers in immunology · 2020
    Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Li YangDivision of Pulmonary Biology, Cincinnati Children's Hospital Medical Center and University of Cincinnati College of Medicine, Cincinnati, OH 45229-3039, USA.
Jan Johansson
Ross Ridsdale
Hanna Willander
Michael Fitzen
Henry T Akinbi
Timothy E Weaver
Cincinnati Children's Hospital Medical Center · USSwedish University of Agricultural Sciences · SE

Funding

Structure/Function Analyses Of SP-BR37HL056285 · NHLBI · CINCINNATI CHILDRENS HOSP MED CTR · PI WEAVER, TIMOTHY EDWARD · 2001 to 2010
$5.0M
STRUCTURE/FUNCTION ANALYSES OF SPBR01HL056285 · NHLBI · CHILDREN'S HOSPITAL MED CTR (CINCINNATI) · PI WEAVER, TIMOTHY EDWARD · 1996 to 2000
$420k
NHLBI NIH HHS HL56285NHLBI NIH HHS R01 HL056285NHLBI NIH HHS R37 HL056285
6 · The paper itself

Abstract

Surfactant protein B (SP-B) proprotein contains three saposin-like protein (SAPLIP) domains: a SAPLIP domain corresponding to the mature SP-B peptide is essential for lung function and postnatal survival; the function of SAPLIP domains in the N-terminal (SP-BN) and C-terminal regions of the proprotein is not known. In the current study, SP-BN was detected in the supernatant of mouse bronchoalveolar lavage fluid (BALF) and in nonciliated bronchiolar cells, alveolar type II epithelial cells, and alveolar macrophages. rSP-BN indirectly promoted the uptake of bacteria by macrophage cell lines and directly killed bacteria at acidic pH, consistent with a lysosomal, antimicrobial function. Native SP-BN isolated from BALF also killed bacteria but only at acidic pH; the bactericidal activity of BALF at acidic pH was completely blocked by SP-BN Ab. Transgenic mice overexpressing SP-BN and mature SP-B peptide had significantly decreased bacterial burden and increased survival following intranasal inoculation with bacteria. These findings support the hypothesis that SP-BN contributes to innate host defense of the lung by supplementing the nonoxidant antimicrobial defenses of alveolar macrophages.

Indexed as

AnimalsAnti-Bacterial AgentsBronchoalveolar Lavage FluidHydrogen-Ion ConcentrationImmunity, InnateKlebsiella pneumoniaeMacrophages, AlveolarMiceMice, TransgenicProtein PrecursorsProtein Structure, TertiaryProteolipidsSaposinsStaphylococcus aureusTissue DistributionAnti-Bacterial AgentsProtein PrecursorsProteolipidsSaposinssurfactant protein B propeptide

Identifiers

PMID20007532
PMCPMC2803329
OpenAlexW2121764927

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.